The overall objective of this project is to define the significance of human glutathione S-transferase _ (hGSTP1-1) polymorphism in cellular detoxication of carcinogenic diol epoxides (DEs) of polycyclic aromatic hydrocarbons, which are widespread environmental pollutants and believed to be etiological factors in human chemical carcinogenesis. Recent preliminary studies indicate that the two polymorphic forms of hGSTP1-1, which differ in their primary structure by a single amino acid in position 104, significantly differ in their activity toward DEs. These observations led the investigators to hypothesize that the hGSTP1-1 polymorphism may be an important determinant of variable response of individuals to PAH-induced cancer. This hypothesis will be tested by a series of experiments proposed under four interrelated specific aims.
In specific aim 1, they will compare the kinetic parameters and catalytic efficiencies of three naturally occurring polymorphic forms of hGSTP1-1 [hGSTP1-1(I104,A113), hGSTP1-1 (V104,A113) and hGSTP1-1(V104,V113)] and hGSTP1-1(I104,V113) form, prepared by site-directed mutagenesis, in the GSH conjugation of various bay-region and fjord-region DEs.
In specific aim 2, we will investigate the effects of overexpression of hGSTP1-1 variants, through stable transfection in HepG2 cells, on cytotoxicity of anti-BPDE and anti-CDE [ultimate carcinogenic metabolite of benzo(a)pyrene and chrysene, respectively] and on formation of2 the predominant DNA adduct of anti-BPDE (trans-N dG-BPD adduct). Studies in specific aim 3 are designed to determine the correlation between expression of hGSTP1-1 variants in humans (by PCR using blood samples from normal healthy subjects as well as cancer patients) and GST activity toward anti-BPDE,2 trans-N dG-BPD adduct formation (in white blood cells of same individuals) and susceptibility to cancer (medical history) of the blood donors. Finally, specific aim 4 is to elucidate the molecular mechanism of differences in the kinetic properties of hGSTP1-1 variants in the GSH conjugation of DEs by X-ray crystallography and molecular modeling of their active sites. These studies should enhance our understanding of the protective mechanisms against carcinogenic DEs and also shed light on the physiological significance of hGSTP1-1 polymorphism in the detoxication of this class of ultimate carcinogens. In the long term, the information generated from this project may be valuable in formulating strategies for cancer prevention in humans and may help in identifying human population at risk for PAH-induced cancer. The proposed studies will assess a total of 408 cases plus and an equal number of controls. The population will consist of members of both genders and will include Caucasians, blacks and other minorities, as available and representative of the patient base at Mercy Hospital.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES009140-02
Application #
2882848
Study Section
Special Emphasis Panel (ZRG4-ALTX-2 (01))
Program Officer
Liu, Yung-Pin
Project Start
1998-03-01
Project End
2002-02-28
Budget Start
1999-03-01
Budget End
2000-02-29
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Mercy Hospital of Pittsburgh
Department
Type
DUNS #
City
Pittsburgh
State
PA
Country
United States
Zip Code
15219
Xiao, Hui; Rawal, Malika; Hahm, Eun-Ryeong et al. (2007) Benzo[a]pyrene-7,8-diol-9,10-epoxide causes caspase-mediated apoptosis in H460 human lung cancer cell line. Cell Cycle 6:2826-34
Xiao, Hui; Singh, Shivendra V (2007) p53 regulates cellular responses to environmental carcinogen benzo[a]pyrene-7,8-diol-9,10-epoxide in human lung cancer cells. Cell Cycle 6:1753-61
Srivastava, Sanjay K; Bansal, Pallavi; Oguri, Tetsuya et al. (2007) Cell division cycle 25B phosphatase is essential for benzo(a)pyrene-7,8-Diol-9,10-epoxide induced neoplastic transformation. Cancer Res 67:9150-7
Singh, Shivendra V; Varma, Vijayalakshmi; Zimniak, Piotr et al. (2004) Structural basis for catalytic differences between alpha class human glutathione transferases hGSTA1-1 and hGSTA2-2 for glutathione conjugation of environmental carcinogen benzo[a]pyrene-7,8-diol-9,10-epoxide. Biochemistry 43:9708-15
Gu, Yijun; Guo, Jianxia; Pal, Ajay et al. (2004) Crystal structure of human glutathione S-transferase A3-3 and mechanistic implications for its high steroid isomerase activity. Biochemistry 43:15673-9
Shami, Paul J; Saavedra, Joseph E; Wang, Lai Y et al. (2003) JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity. Mol Cancer Ther 2:409-17
Srivastava, Sanjay K; Watkins, Simon C; Schuetz, Erin et al. (2002) Role of glutathione conjugate efflux in cellular protection against benzo[a]pyrene-7,8-diol-9,10-epoxide-induced DNA damage. Mol Carcinog 33:156-62
Awasthi, S; Cheng, J Z; Singhal, S S et al. (2001) Functional reassembly of ATP-dependent xenobiotic transport by the N- and C-terminal domains of RLIP76 and identification of ATP binding sequences. Biochemistry 40:4159-68
Pandya, U; Srivastava, S K; Singhal, S S et al. (2000) Activity of allelic variants of Pi class human glutathione S-transferase toward chlorambucil. Biochem Biophys Res Commun 278:258-62
Pal, A; Desai, D H; Amin, S et al. (2000) Location of the epoxide function determines specificity of the allelic variants of human glutathione transferase Pi toward benzo[c]chrysene diol epoxide isomers. FEBS Lett 486:163-6

Showing the most recent 10 out of 18 publications